U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07323680) titled 'Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects' on Dec. 18, 2025.
Brief Summary: The purpose of this study is to compare the safety, pharmacokinetics, and pharmacodynamic effects of aspirin administered intravenously with aspirin administered orally.
Study Start Date: June 15, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: 325 mg Oral Aspirin
Drug: aspirin 325mg
* Subjects will be administered 325 mg aspirin orally
DRUG: 325 mg aspirin by rapid IV push
Drug: Rho-11 Subjects will be administered 325 m...